Product Code: PHARMACO[DPYD/UGT1A1]-25
From £455.00
Registration closed: 28/02/2025
Applicable to all labs undertaking molecular testing of DPYD and/or UGT1A1 pharmacogenetic markers for drug response and efficacy.
Any molecular test, CNV, MLPA, NGS, Panel testing, PCR based, Sanger sequencing, Single gene testing, Targeted testing, Whole exome sequencing
English, German
DNA (in TE Buffer)
Pending
The scheme is designed to assess the analytical process (genotyping), and reporting (biological and clinical interpretation of the test result) including the overall report layout, content and clerical accuracy.
Three mock clinical cases with matching samples will be
provided. Approximately 2-4µg DNA per sample is provided. Complete
information will be available in the scheme instructions.
Participants will receive an individual report including educational advice and a scheme report which includes additional information from the cohort of participants including geographical spread, methodologies employed, common errors, learning points and scheme statistics allowing participants to benchmark their results.
Each laboratory will also receive a single certificate listing all EQAs participated in with performance result for each year.
No restrictions on number of participants. Open to laboratories from ALL countries (note: some restrictions may apply*)
*Sanctions, delivery network exceptions, restrictions on importation etc.
added wishlist!
View Wishlist
View Wishlist
Express your interest in ''.